Sunil Healthcare Gains 2.86%: Financial Struggles and Valuation Shifts Shape the Week
2026-11-21 17:09:55Key Events This Week Nov 16: Stock opens at Rs.72.00, up 2.86% Nov 17: Price surges 5.56% to Rs.76.00 amid valuation upgrade Nov 18: Reports negative financial trend; stock drops 5.20% to Rs.72.05 Nov 19: Price declines further by 2.85% to Rs.70.00 Nov 20: Downgrade to Strong Sell announced; stock rebounds 2.86% to Rs.72.00 Week OpenRs.70.00 ...
Read More
Sunil Healthcare Ltd Downgraded to Strong Sell Amid Financial and Technical Weakness
2026-11-20 08:08:58Sunil Healthcare Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its financial performance, valuation metrics, technical indicators, and overall quality. The downgrade reflects deteriorating fundamentals and a cautious outlook for the micro-cap pharmaceutical company amid a challenging market environment.
Read More
Sunil Healthcare Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-11-18 08:01:48Sunil Healthcare Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, reflecting a recalibration of price appeal within the Pharmaceuticals & Biotechnology sector. Despite a micro-cap status and a recent downgrade in its Mojo Grade to Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling investment case relative to peers and historical benchmarks.
Read More
Sunil Healthcare Ltd is Rated Sell
2026-11-05 10:10:46Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 November 2026, providing investors with the latest insights into its performance and outlook.
Read More
Sunil Healthcare Ltd is Rated Sell
2026-10-23 10:10:18Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read More
Sunil Healthcare Ltd is Rated Sell
2026-10-06 10:10:18Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 06 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Sunil Healthcare Ltd is Rated Sell
2026-09-25 10:11:00Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Sunil Healthcare Ltd is Rated Sell by MarketsMOJO
2026-09-05 10:10:29Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Sunil Healthcare Ltd Valuation Improves Amid Strong Price Performance
2026-08-31 08:00:19Sunil Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling improved price appeal for investors within the Pharmaceuticals & Biotechnology sector. This upgrade accompanies a strong recent price performance and a positive revision in its Mojo Grade from Sell to Hold, reflecting growing market confidence despite broader sector headwinds.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2026 | Source : BSECopy of newspaper publication of financial results for the quarter and half year ended 30.09.2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2026
13-Nov-2026 | Source : BSEOutcome of Board Meeting held on 13th November 2026
Approved Financial Results For The Quarter And Half Year Ended 30.09.2026
13-Nov-2026 | Source : BSEApproved Financial Results (both standalone and consolidated) for the quarter and half year ended 30.09.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available